Drug DevelopmentContact Us
Southern Research Drug Development provides commercial and government clients with a wide variety of nonclinical and clinical trial support services. We offer an array of studies including both in vitro and in vivo testing of small molecule compounds, vaccines, biologics and other test articles in therapeutic areas, such as infectious disease, CNS and cancer. Our nationally recognized team of dedicated individuals provides expertise and services spanning from basic research to advanced studies under FDA GLP regulations.
Southern Research joined the front lines in the battle against HIV/AIDS in 1986, not long after the deadly viral infection emerged in the U.S. as a terrifying new public health threat. Over the years, our innovative scientists have supported drug and vaccine discovery and development efforts led by industry and government partners. As a result of this longstanding dedication to fight HIV/AIDS, Southern Research has helped 90% of all currently approved antivirals get to market. Today we continue to offer developers one-of-a-kind solutions from high-throughput screening systems, to our unique collection of drug resistant clinical HIV isolates, to the newly fielded Quantitative Viral Outgrowth Assay (QVOA), the only universally accepted assay for measuring the frequency of latently infected cells in patients receiving antiretroviral therapy (ART). On World AIDS Day, December 1, 2017, the NIH announced we are closer than ever to the beginning of the end of the HIV/AIDS pandemic. That’s why Southern Research has reaffirmed our commitment to support HIV/AIDS advancements from discovery to post-marketing surveillance. In this video, hear from Susan Schader, Ph.D., researcher for SR Drug Development, on the significance of HIV/AIDS research as we move into 2018.
Drug Development Services
How To Work With Us
As a CRO service provider, Southern Research’s Drug Development division has a straightforward business model. Contact our business development representative by clicking here. A confidentiality disclosure agreement will be initiated (your agreement or ours) to facilitate detailed discussions around your specific needs. One of our subject matter experts will be brought into the discussion to ensure we have a comprehensive understanding of your project. A proposal will then be prepared, outlining the tasks to be accomplished, along with a budget and timeline. Upon acceptance of the proposal, a contract will be provided to establish the legal framework for the project.
Drug Development News
With experts predicting another deadly influenza pandemic in the future, Southern Research scientists are working on several fronts to help limit the death toll from a catastrophic flu outbreak that […]
Southern Research reproductive toxicology scientist Paul Bushdid, Ph.D., is working to develop a new, cost-efficient laboratory test to evaluate hazards to unborn children posed by potential medicines, chemicals and other […]
Southern Research has been awarded two contracts from the Biomedical Advanced Research and Development Authority (BARDA), which is a division of the U.S. Department of Health and Human Services’ Office […]